NFE2L2 and chronic obstructive pulmonary disease: Our results demonstrated that GSH-related Nrf2 signaling pathway can be pharmacologically manipulated by AZI, which may provide new possibilities in the treatment of airway epithelium damage-related respiratory diseases induced by CS, such as COPD.